Position
Pfizer Inc in Pyxis Oncology, Inc.
Back to the book · All holders of PYXS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.13M$1.15 → $1.31
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 7.03M | $8.09M | — | — | — | 3.4% |
| Q1 2026 | 7.03M | $9.21M | $1.31 | $1.13M | −$0 | 3.9% |